Product image of Tektrotyd (Hynic-[d-Phe1,tyr3-Octreotide]*tfa) supplied by GNH India

Tektrotyd

Active Ingredient:
Hynic-[d-Phe1,tyr3-Octreotide]*tfa
Origin:
EU

Tektrotyd (Hynic-[d-Phe1,tyr3-Octreotide]*tfa)

Tektrotyd is a radiopharmaceutical used in diagnostic imaging, particularly for somatostatin receptor-positive neuroendocrine tumors. This Hynic-[d-Phe1,tyr3-Octreotide]*tfa formulation supports nuclear medicine procedures. It is administered intravenously under professional supervision. Ideal for patients requiring targeted diagnostic imaging.

Manufacturer / TM Owner

Narodowe Centrum Badań Jądrowych

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Tektrotyd is primarily used in nuclear medicine for imaging somatostatin receptor-positive neuroendocrine tumors. It helps visualize tumors by binding to somatostatin receptors, aiding in diagnosis and treatment planning. This radiopharmaceutical is also used in other conditions where somatostatin receptor imaging is beneficial, such as certain types of pancreatic and gastrointestinal tumors.

Side Effects

  • Tektrotyd works by targeting somatostatin receptors commonly found on neuroendocrine tumors. After administration, it binds to these receptors, allowing imaging techniques to highlight areas with high receptor density. Patients may experience temporary effects such as mild discomfort at the injection site or mild systemic reactions like nausea.

Precautions & Warnings

  • Tektrotyd should only be handled and administered by trained healthcare professionals in a controlled clinical setting. Patients should disclose their full medical history, including allergies and current medications. Pregnant or breastfeeding individuals should avoid this radiopharmaceutical unless absolutely necessary. Proper hydration before and after administration is recommended.

Avoid Interactions

  • Tektrotyd may interact with other radiopharmaceuticals or medications affecting somatostatin receptors. Patients using somatostatin analogs or undergoing other nuclear medicine procedures should inform their healthcare provider. Alcohol and certain foods do not typically interact but should be discussed with a medical professional. Always review concurrent medications for potential interactions.

Frequently Asked Questions

Tektrotyd is used in diagnostic imaging to detect somatostatin receptor-positive neuroendocrine tumors.

Tektrotyd is administered intravenously by a healthcare professional in a clinical setting.

Common effects may include mild discomfort at the injection site or mild systemic reactions like nausea.

Pregnant individuals should avoid Tektrotyd unless medically necessary, as it involves radiation exposure.

Patients should disclose all medications to their healthcare provider to assess potential interactions.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Hynic-[d-Phe1,tyr3-Octreotide]*tfa

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT